Trial Profile
A Randomized, Double-blind, Placebo-controlled, Investigator-initiated Study to Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Orlistat (Primary) ; Sibutramine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 04 Sep 2010 New trial record